Cancer Research Communications: 2024, vol: , issue:
- 1)- Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey, Ji-Ying Song, Danielle Hulsman, Oscar Krijgsman, Gayathri Chandrasekaran, Anton Berns, Maarten van Lohuizen. Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant Mesothelioma. Cancer research communications. 2024, 4 (1): 18-27
Cited : 1Read More - 2)- Josep Tabernero, Takayuki Yoshino, Sebastian Stintzing, Aimery de Gramont, Peter Gibbs, Derek J Jonker, Peter Nygren, Christos Papadimitriou, Gerald W Prager, Roger Tell, Heinz-Josef Lenz. A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT Trial. Cancer research communications. 2024, 4 (1): 28-37Cited : 3Read More
- 3)- Poornima Bhat-Nakshatri, Aditi S Khatpe, Duojiao Chen, Katie Batic, Henry Mang, Christopher Herodotou, Patrick C McGuire, Xiaoling Xuei, Cihat Erdogan, Hongyu Gao, Yunlong Liu, George Sandusky, Anna Maria Storniolo, Harikrishna Nakshatri. Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R Oncogene. Cancer research communications. 2024, 4 (1): 38-54Cited : 3Read More
- 4)- Frederick Nguele Meke, Yunpeng Bai, Diego Ruiz-Avila, Colin Carlock, Jinan Ayub, Jinmin Miao, Yanyang Hu, Qinglin Li, Zhong-Yin Zhang. Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53-deficient Sarcoma and Lymphoma Mouse Models. Cancer research communications. 2024, 4 (1): 5-17Cited : 3Read More
- 5)- Makoto Nishio, Shuji Murakami, Hisato Kawakami, Kyoichi Okishio, Motohiro Tamiya, Haruki Kobayashi, Daichi Fujimoto, Shunichi Sugawara, Toshiyuki Kozuki, Yuko Oya, Hiroki Izumi, Takayuki Shiroyama, Miyako Satouchi, Noboru Yamamoto, Shota Kaname, Daiko Matsuoka, Yohei Otake, Takao Takase, Taro Semba, Koichi Azuma. Phase 2 Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort. Cancer research communications. 2024, : Cited : 2Read More
- 6)- Maira Soto, Erin L Filbert, Hai Yang, Stephanie Starzinski, Alec Starzinski, Marissa Gin, Brandon K Chen, Phi Le, Tony Li, Brandon Bol, Alexander Cheung, Li Zhang, Frank J Hsu, Andrew H Ko, Lawrence Fong, Bridget P Keenan. Neoadjuvant CD40 agonism remodels the tumor immune microenvironment in locally advanced esophageal/gastroesophageal junction cancer. Cancer research communications. 2024, : Cited : 1Read More
- 7)- Marco Napoli, Avani A Deshpande, Deepavali Chakravarti, Kimal Rajapakshe, Preethi H Gunaratne, Cristian Coarfa, Elsa R Flores. Genome-wide p63-target gene analyses reveal TAp63/NRF2-dependent oxidative stress responses. Cancer research communications. 2024, : Cited : 0Read More
